Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
08/2010
08/18/2010EP2217066A1 Nitrosubstituted aryloxyalkylimidazolines for use as pesticides
08/18/2010EP1940786B1 Biphenyl derivatives and their use in treating hepatitis c
08/18/2010EP1735275B1 Aryl sulfones and uses related thereto
08/18/2010CN101809001A Imidazole derivatives
08/18/2010CN101809000A Compounds with a combination of cannabinoid-CB1 antagonism and serotonin reuptake inhibition
08/18/2010CN101808995A Novel glucokinase activators and methods of using same
08/18/2010CN101805361A Double-shell hollow spherical organic metal framework material and preparation method thereof
08/18/2010CN101805296A Preparation method of 1-(4-bromophenyl methyl)-2-n-butyl-4-chloro-1H-imidazole-5-formaldehyde
08/18/2010CN101805295A Method for synthesizing trisubstituted imidazole medicament molecules and analogue thereof
08/18/2010CN101805294A Preparation of dexmedetomidine hydrochloride key intermediate
08/18/2010CN101805293A 1 (dimethylamino) ethyl, 3-hydroxy-imidazoline hydrochloride and preparation method thereof
08/18/2010CN101284816B Chiral N-2-(glyoxaline-1-group) fatty acid amide and method for preparing same
08/17/2010US7777074 Amino acid compounds
08/17/2010US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis
08/17/2010US7776901 4-(6-spiro-1'-Cyclopropane-1a,6-dihydro-1H-cyclopropa[a]inden-6a-yl)-1H-imidazole, used for the treatment where the memory deficiency is associated with Alzheimer's disease and memory deficiency induced by scopolamine; side effect reduction
08/17/2010CA2370412C Pharmaceutical compounds
08/17/2010CA2325471C Piperididinyl and n-amidinopiperidinyl derivatives
08/12/2010WO2010091164A1 Inhibitors of glucosylceramide synthase
08/12/2010WO2010090954A1 Novel trifluoromethylsulfonamide gamma secretase inhibitor
08/12/2010WO2010090200A1 Phenylimidazole compounds
08/12/2010US20100204288 Heteroaryl-Ureas and Their Use as Glucokinase Activators
08/12/2010US20100204260 synthesis of new class of nonsteroidal antiinflammatory and antibacterial agent for use treating septic shock, asthma, arthritis, cancer; e.g. 1-Benzyl-2,4,5-triphenyl-4,5-dihydro-1H-imidazole-4-carboxylic acid
08/12/2010US20100204236 Substituted imidazoles as bombesin receptor subtype-3 modulators
08/12/2010US20100204233 Imidazole derivatives
08/12/2010US20100203135 Skin Equivalent Culture
08/12/2010CA2750704A1 Phenylimidazole compounds
08/11/2010EP2216334A1 Hiv protease inhibiting sulfonamides
08/11/2010EP1768962B1 Method for producing onium salts with a low chloride content
08/11/2010EP1685095B1 Method for the production of organic salts containing bis(perfluoroalkyl)phosphinate anions
08/11/2010EP1484301B1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
08/11/2010CN101798298A Imidazole derivatives
08/11/2010CN101798286A 1-(3-chlorine-2-hydroxyl-propyl)-3-alkyl imidazole ionic liquid and preparation method thereof
08/11/2010CN101161644B Hydroxy nidazole compound and preparation method and uses thereof
08/10/2010US7772425 Vitamin D receptor modulators
08/10/2010US7772403 oxidation and chlorination of 5S)-5-[(benzylthio)methyl]-, 5S)-5-[(tert-butylthio)methyl]- or (5S)-5-[(tert-butylsulfinyl)methyl]-, 5-methylimidazolidine-2,4-dione, in a one pot process to yield [(4S)-4-Methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride
08/10/2010CA2237099C Sulfonylaminocarboxylic acids
08/05/2010WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010WO2010087419A2 Ester compound and use thereof
08/05/2010US20100197935 Crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it
08/05/2010US20100197934 Process for producing optically active alpha-methylcysteine derivative
08/05/2010US20100197924 Preparation of aminotetralin compounds
08/05/2010US20100197886 Modified polymer complex, complex monomer, polymer complex, and redox,catalyst
08/05/2010US20100197752 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases
08/05/2010US20100197734 Pleuromutilin derivatives and their use as antimicrobials
08/05/2010US20100197696 Pesticidal heterocyclic dihaloallyl compounds
08/05/2010US20100197675 Cyclic urea and carbamate inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
08/05/2010US20100197644 Chemical Compounds 572
08/05/2010CA2750452A1 N-acyl anthranilic acid derivative or salt thereof
08/04/2010EP2212314A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators
08/04/2010EP2212284A2 Calcium receptor modulating agents
08/04/2010EP1392660B1 Substituted benzoylcyclohexenones and their use as herbicidal agents
08/04/2010CN101796020A Novel triazine compounds for treatment of cancer
08/04/2010CN101795997A Distillation of ionic liquids
08/03/2010US7767852 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
08/03/2010US7767826 reacting histidine methyl ester with benzoyl chloride, then the hydrolysis of the alkyl-(S,Z)-2,4,5-triamidopent-4-enoate formed followed by reaction with a metal thiocyanate to obtain a thiohistidine, protecting of the sulfur of the thiohistidine, quaternization of the amine and deprotection
08/03/2010US7767824 5,5-dibenzylimidazo[2,1-b]thiazol-6(5H)-one, useful as cognition activators in connection with treatments on memory disturbance, memory acquirement and retention disturbance, for example in Alzheimer's disease
08/03/2010US7767811 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767704 viricides such as N-(3-Chloropropyl)-1-methyl-4-[({[4-(trifluoromethoxy)phenyl]amino}carbonyl)amino]-1H-imidazol-2-carboxamide, used for treating cytomegalovirus infections in humans or animals
08/03/2010US7767667 Pesticidal heterocycles
08/03/2010CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors
07/2010
07/29/2010WO2010084908A1 Organic electroluminescent device
07/29/2010WO2010084186A1 Salts and polymorphs of a kinesin inhibitor compound
07/29/2010WO2010083633A1 Compounds uesed for anti-hypertension, preparation methods, compositions and uses thereof
07/29/2010US20100190766 Antibacterial agents
07/28/2010EP1763511B1 Phenoxyacetic acid derivatives as ppar agonists
07/28/2010CN101786991A Substituted tetracycline compounds
07/28/2010CN101786990A Compound having anti-itching activity
07/28/2010CN101786989A 4,4-di(4,4,5,5-tetramethyl imidazoline-3-oxidation-1-oxy radical) phenyl ether and preparation method thereof
07/28/2010CN101786988A Synthesizing method of porous ion liquid polymer
07/28/2010CN101786962A Method for producing amino acid chelate iron
07/27/2010US7763662 reducing weight in mammals; Substituted with a thio, sulfoxy or sulfonyl group eg 5-Chloro-2-methylsulfonylindan-1-ol, 5-Chloro-2-(propane-2-sulfonyl)indan-1-ol, 5-Chloro-2-ethanesulfonylindan-1-ol
07/27/2010US7763649 Treating cardiac arrhythmia and/or cancerous and pre-cancerous cells by administering specific synthetic carotenoid analogs or derivatives either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation
07/27/2010US7763641 such as [(1S,2R)-2-hydroxy-3-[N-[4-(2-methylaminothiazol-4-yl)phenylsulfonyl]-N-(2-methylpropyl)amino]-1-(phenylmethyl)propyl]carbamic acid, [(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl]ester, used for treating human immunodeficiency virus infections
07/27/2010CA2436659C Cannabinoid receptor ligands
07/22/2010WO2010008213A9 Silane based compound, method for preparing the same, and surface treating agent composition for copper foil including the silane based compound
07/22/2010US20100184982 Detergent-dispersant, additive composition for lubricant, and lubricant composition
07/22/2010US20100184974 Protease Inhibitors
07/22/2010US20100184796 Agonists of bitter taste receptors and uses thereof
07/22/2010US20100184737 Imidazole compounds for the treatment of neurological disorders
07/22/2010US20100184097 4,5-bis(4-methoxyphenyl)imidazole compound inducing differentiation of myoblasts or muscle fibers into neuron cells, a pharmaceutical composition including said compound, a method of inducing neuron cells differentiation and a screening method for identifying additional compound useful for inducing neuron cells differentiation
07/22/2010US20100183712 Acylated indanyl amines and their use as pharmaceuticals
07/21/2010EP2208727A1 Diaryl ethers as opioid receptor antagonist
07/21/2010EP2207421A1 Haloalkylsubstituted aryloxyalkylimidazolines for use as pesticides
07/21/2010EP1917250B1 Anti-inflammatory aryl nitrile compounds
07/21/2010EP1605078B1 Soldering process using imidazole compound
07/21/2010EP1079825B1 Compounds that inhibit the binding of integrins to their receptors
07/21/2010CN1826310B Novel aminobenzophenone compounds
07/21/2010CN101784542A Imidazolone derivatives, preparation method thereof and biological use of same
07/21/2010CN101781330A Propofol, phosphate and amino acid double salt and preparation method and application thereof
07/21/2010CN101781274A Acylated piperazine dipeptidyl peptidase IV inhibitor
07/21/2010CN101781273A dipeptidylpeptidase iv inhibitor containing guanidyl
07/21/2010CN101781255A Preparation method of 2-n-butyl-4(5)-chlor-5(4)-formaldehyde-1H-imidazole
07/21/2010CN101781254A Gemini ionic liquid with fluorous biphasic property, and catalyst prepared by utilizing ionic liquid and application thereof
07/21/2010CN101781253A Method for preparing gemini ionic liquid with fluorous biphasic property
07/21/2010CN101781252A Method for preparing functionalized acidic ionic liquid with fluorous biphasic property
07/21/2010CN101781251A Functionalized acidic ionic liquid with fluorous biphasic property and application thereof
07/21/2010CN101781250A Method for synthesizing low bromine content iminazole ionic liquid
07/21/2010CN101041635B Method for synthesizing ketenes amine condensation derivatives
07/20/2010US7759496 4-[6(2,2-dimethylpropanoyloxy)indan-1-ylmethyl]1H-imidazole, an alpha 2 adrenergic agonist, for the treatment of hypertension, glaucoma, headaches, diarrhea, ischemia, drug abuse and dependence, hypotension, shock, congestive heart failure, anxiety, as decongestants, analgesics or as sedatives
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 345